Viridian Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 16.60 M | $305.03 M | 7.97% | 15.39% |
| BLACKROCK, INC. | 08/07/2026 | 8.55 M | $157.09 M | 9.19% | 7.93% |
| BELLEVUE GROUP AG | 08/14/2026 | 6.73 M | $123.67 M | 0.09% | 6.24% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2026 | 6.72 M | $123.52 M | 113.53% | 6.23% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 6.45 M | $118.56 M | 175.61% | 5.98% |
| STATE STREET CORP | 08/07/2026 | 6.12 M | $112.52 M | 31.07% | 5.68% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 5.75 M | $105.60 M | 79.30% | 5.33% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2026 | 5.09 M | $93.52 M | 30.05% | 4.72% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.58 M | $84.08 M | 9.83% | 4.24% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 3.59 M | $66.00 M | 157.74% | 3.33% |
| VR ADVISER, LLC | 08/14/2026 | 3.26 M | $59.85 M | -16.09% | 3.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 3.13 M | $57.47 M | 1.62% | 2.90% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 2.75 M | $50.57 M | 67.70% | 2.55% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.50 M | $45.97 M | 7.23% | 2.32% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2026 | 2.50 M | $45.93 M | 66.67% | 2.32% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 2.38 M | $43.78 M | 20.86% | 2.21% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 2.34 M | $43.04 M | 625.82% | 2.17% |
| CALIGAN PARTNERS LP | 08/14/2026 | 2.19 M | $40.30 M | 100.00% | 2.03% |
| NOVO HOLDINGS A/S | 08/14/2026 | 2.14 M | $39.22 M | 6.75% | 1.98% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.79 M | $32.93 M | 0.00% | 1.66% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 1.75 M | $32.16 M | -0.99% | 1.62% |
| CANDRIAM S.C.A. | 08/13/2026 | 1.71 M | $31.34 M | 139.93% | 1.58% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.69 M | $31.07 M | 6.24% | 1.57% |
| FIRST TURN MANAGEMENT, LLC | 08/14/2026 | 1.67 M | $30.68 M | 83.25% | 1.55% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.61 M | $29.61 M | 204.20% | 1.49% |
| UBS GROUP AG | 08/13/2026 | 1.43 M | $26.25 M | 365.22% | 1.32% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 1.39 M | $27.22 M | -0.03% | 1.29% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 1.38 M | $25.31 M | 146.91% | 1.28% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 1.28 M | $23.51 M | -44.74% | 1.19% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 1.18 M | $21.72 M | -6.36% | 1.10% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2026 | 1.18 M | $21.60 M | 30.86% | 1.09% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 1.11 M | $20.44 M | 4,678.61% | 1.03% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 1.01 M | $18.59 M | 279.93% | 0.94% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 999.92 K | $18.37 M | 12.57% | 0.93% |
| ELMIND CAPITAL, LP | 08/14/2026 | 984.93 K | $18.09 M | 84.12% | 0.91% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 944.35 K | $17.35 M | -18.84% | 0.88% |
| NORTHERN TRUST CORP | 08/13/2026 | 863.49 K | $15.86 M | 23.89% | 0.80% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 831.14 K | $15.27 M | 16.53% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 815.03 K | $14.97 M | 11.96% | 0.76% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 815.03 K | $14.97 M | 100.00% | 0.76% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2026 | 793.51 K | $14.58 M | 100.00% | 0.74% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 768.60 K | $14.12 M | 278.43% | 0.71% |
| MORGAN STANLEY | 08/13/2026 | 728.82 K | $13.39 M | -16.24% | 0.68% |
| WOODLINE PARTNERS LP | 08/14/2026 | 700.93 K | $12.88 M | 0.00% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 657.59 K | $12.08 M | 11.22% | 0.61% |
| JPMORGAN CHASE & CO | 08/12/2026 | 639.93 K | $12.11 M | -39.62% | 0.59% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 581.98 K | $10.69 M | -50.29% | 0.54% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 541.06 K | $9.94 M | 100.00% | 0.50% |
| EMERALD ADVISERS, LLC | 08/05/2026 | 537.33 K | $9.87 M | 100.00% | 0.50% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 482.88 K | $8.87 M | -53.22% | 0.45% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Viridian Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 300 institutional investors and hedge funds held shares of Viridian Therapeutics Inc. The most heavily invested institutionals were:
FMR LLC: 16.6 M
BlackRock, Inc.: 8.55 M
Bellevue Group AG: 6.73 M
Paradigm Biocapital Advisors LP: 6.72 M
Kynam Capital Management, LP: 6.45 M
STATE STREET CORP: 6.12 M
126.86% of Viridian Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 149.97 M shares in the last 24 months. This purchase volume represents approximately $4.45 B in transactions.